9th Annual Biomarkers Congress

View Profile


Peer Reviewed Papers, Books, Chapters

Year Title Citation Authors
1. 2009
2. 2008 RNA Aptamer-targeted Inhibition of NF-kappaB Suppresses Non-small Cell Lung Cancer Resistance to Doxorubicin. Mol Ther 16, 66-73.
3. 2007 The potential role of intrinsic hypoxia markers as prognostic variables in cancer   Antioxidants & redox signaling 2007;9(8):1237-94.
4. 2007 Three-dimensional imaging of whole rodent organs using optical computed and emission tomography. Journal of biomedical optics 2007;12(1):014009.
5. 2007 Magnetic resonance imaging of temperature-sensitive liposome release: drug dose painting and antitumor effects. Journal of the National Cancer Institute 2007;99(1):53-63.
6. 2007 Long-term administration of a small molecular weight catalytic metalloporphyrin antioxidant, AEOL 10150, protects lungs from radiation-induced injury. International journal of radiation oncology, biology, physics 2007;67(2):573-80
7. 2007 Functional imaging in bulk tissue specimens using optical emission tomography: fluorescence preservation during optical clearing. Physics in medicine and biology 2007;52(8):2035-54.
8. 2007 A phase I trial of hyperthermia-induced interleukin-12 gene therapy in spontaneously arising feline soft tissue sarcomas. Molecular cancer therapeutics. 2007;6(1):380-9.
9. 2007 Epinephrine-induced activation of LW-mediated sickle cell adhesion and vaso-occlusion in vivo. Blood
10. 2007 Radiation and a metalloporphyrin radioprotectant in a mouse prostate tumor model. Anticancer Res. 2007; (5A):3101-9.
11. 2007 Low molecular weight catalytic metalloporphyrin antioxidant AEOL 10150 protects lungs from franctionated radiation. Free Radic Res. 2007; 1-10.
12. 2007 Inhibition of In Vivo tumor Angiogenesis and Growth Via Systemic Delivery of an Angiopoietin 2-specific RNA Aptamer. J Surg Res.
13. 2007 Online feedback focusing algorithm for hyperthermia cancer treatment Int J Hyperthermia.
14. 2007 RNA Aptamer-targeted Inhibition of NF-kappaB Suppresses Non-small Cell Lung Cancer Resistance to Doxorubicin Mol Ther.
15. 2007 Self- consistent tumor control probability and normal tissue complication probability models based on generalized EUD Med Phys. 2007; 34(7):2807-15.
16. 2007 Use of bioluminescence imaging to detect enhanced hepatic and systemic tumor growth following partial hepatectomy in mice. Eur J Surg Oncol.
17. 2007 Tumor angiogenic and hypoxic profiles predict radiographic response and survival in malignant astrocytoma patients treated with bevacizumab and irinotecan. J Clin Oncol 26, 271-278.
18. 2007 Treatment with imatinib improves drug delivery and efficacy in NSCLC xenografts. British Journal of Cancer 97, 735-740.
19. 2007 Predicting lung radiotherapy-induced pneumonitis using a model combining parametric Lyman probit with nonparametric decision trees International journal of radiation oncology, biology, physics 2007;68(4):1212-21
20. 2007 An in vitro system to evaluate the effects of ischemia on survival of cells used for cell therapy. Annals of biomedical engineering 2007;35(8):1414-24.
21. 2007 Intermittent hypoxia furthers the rationale for hypoxia-inducible factor-1 targeting. Cancer research 2007;67(3):854-5.
22. 2007 Angiostatin-like activity of a monoclonal antibody to the catalytic subunit of F1F0 ATP synthase Cancer research 2007;67(10):4716-24.
23. 2007 Exploring the role of HIF-1 in early angiogenesis and response to radiotherapy. Radiother Oncol 2007;83(3):249-55.
24. 2007 Multiple etiologies of tumor hypoxia require multifaceted solutions. Clin Cancer Res 2007;13(2 Pt 1):375-7.
25. 2007 Thermal cycling enhances the accumulation of a temperature-sensitive biopolymer in solid tumors. Cancer research 2007;67(9):4418-24.
26. 2007 Arcasoy MO. Erythropoietin blockade inhibits the induction of tumor angiogenesis and progression. PLoS ONE 2007;2:e549.
27. 2007 Requirements for T lymphocyte migration in explanted lymph nodes.   J Immunol 2007;178(12):7747-55.
28. 2007 Systemic overexpression of angiopoietin-2 promotes tumor microvessel regression and inhibits angiogenesis and tumor growth Cancer research 2007;67(8):3835-44.
29. 2007 Targeting the molecular effects of a hypoxic tumor microenvironment Front Biosci 2007;12:4061-78.
30. 2007 Regulation of HIF-1alpha stability through S-nitrosylation. Molecular cell 2007;26(1):63-74.
31. 2007 Effects of fluctuating oxygenation on tirapazamine efficacy: Theoretical predictions International journal of radiation oncology, biology, physics 2007;67(2):581-6.
32. 2007 Hypoxia and radiotherapy: opportunities for improved outcomes in cancer treatment Cancer metastasis reviews 2007;26(2):241-8.
33. 2006 Changes in tumour oxygenation during fractionated hyperthermia and radiation therapy in spontaneous canine sarcomas. Int J Hyperthermia, 22: 365-373
34. 2006 Chemodosimetry of in vivo tumor liposomal drug concentration using MRI. Magn Reson Med, 56: 1011-1018
35. 2006 Treatment with Imatinib in NSCLC is associated with decrease of phosphorylated PDGFR-beta and VEGF expression, decrease in interstitial fluid pressure and improvement of oxygenation. Br J Cancer, 95: 1013-1019
36. 2006 Tumor necrosis factor-alpha is a potent endogenous mutagen that promotes cellular transformation. Cancer research 2006;66(24):11565-70
37. 2006 Apoptotic DNA fragmentation factor maintains chromosome stability in a P53-independent manner. Oncogene 2006;25(39):5370-6
38. 2006 Anti-angiogenic effects of interleukin-12 delivered by a novel hyperthermia induced gene construct Int J Hyperthermia, 22: 587-606
39. 2006 New PEG-ylated Mn(III) porphyrins approaching catalytic activity of SOD enzyme. Dalton Trans:617-24
40. 2006 Tumor vascular permeability, accumulation, and penetration of macromolecular drug carriers J Natl Cancer Inst 98:335-44
41. 2006 Gene expression profiles of multiple breast cancer phenotypes and response to neoadjuvant chemotherapy. Clin Cancer Res 12:819-26,
42. 2006 Erythropoietin biology in cancer. Clin Cancer Res 12:332-9
43. 2006 Erythropoietin inhibits apoptosis in breast cancer cells via an Akt-dependent pathway without modulating in vivo chemosensitivity Mol Cancer Ther 5:356-61
44. 2006 The effect of darbepoetin alfa on growth, oxygenation and radioresponsiveness of a breast adenocarcinoma. Radiat Res 165:192-201
45. 2006 Optimizing a novel regional chemotherapeutic agent against melanoma: hyperthermia-induced enhancement of temozolomide cytotoxicity. Clin Cancer Res 12:289-97
46. 2006 Direct demonstration of instabilities in oxygen concentrations within the extravascular compartment of an experimental tumor. Cancer Res 66:2219-23,
47. 2006 A comparison of antiangiogenic therapies for the prevention of liver metastases . J Surg Res 131:97-104
48. 2006 A unique role of the DNA fragmentation factor in maintaining genomic stability. A unique role of the DNA fragmentation factor in maintaining genomic stability.
49. 2006 Phase I trial of Doxorubicin-containing low temperature sensitive liposomes in spontaneous canine tumors. Clin Cancer Res 12: 4004-4010
50. 2006 Z ROS production and angiogenic regulation by macrophages in response to heat therapy Int J Hyperthermia 22: 263-273
51. 2006 Z Intra-peritoneal cisplatin and whole abdomen hyperthermia for relapsed ovarian carcinoma Int J Hyperthermia 22: 161-172
52. 2006 The G12 family of heterotrimeric G proteins promotes breast cancer invasion and metastasis. Proc Natl Acad Sci U S A 103: 8173-8178
53. 2006 HIF-1 and tumour radiosensitivity. Br J Cancer 95: 1-5
54. 2006 Hyperthermia mediated liposomal drug delivery Int J Hyperthermia 22: 205-213,
55. 2006 PR Characterization of a recombinant adenovirus vector encoding heat-inducible feline interleukin-12 for use in hyperthermia-induced gene-therapy Int J Hyperthermia 22: 117-134
56. 2006 A tracer dose of technetium-99m-labeled liposomes can estimate the effect of hyperthermia on intratumoral doxil extravasation Clin Cancer Res 2006;12(22):6800-7.
57. 2006 A methodology for using SPECT to reduce intensity-modulated radiation therapy (IMRT) dose to functioning lung. International journal of radiation oncology, biology, physics 2006;66(5):1543-52.
58. 2006 OI A clinically proven, prospective, thermal dose descriptor exists. Clin Cancer Res12: 1944-1945
59. 2006 Quantitative comparison of the inhibitory effects of GW5638 and tamoxifen on angiogenesis in the cornea pocket assay. Angiogenesis
60. 2006 Apoptotic DNA fragmentation factor maintains chromosome stability in a P53-independent manner. Oncogene
61. 2006 Intertumoral differences in hypoxia selectivity of the PET imaging agent 64Cu(II)-diacetyl-bis(N4-methylthiosemicarbazone). J Nucl Med 47: 989-998
62. 2006 Camptothecin analogs with enhanced activity against human breast cancer cells. II. Impact of the tumor pH gradient. Cancer Chemother Pharmacol, 57: 145-154
63. 2006 Assessing the ability of the antiangiogenic and anticytokine agent thalidomide to modulate radiation-induced lung injury. Int J Radiat Oncol Biol Phys, 66: 477-482
64. 2006 Glioma stem cells promote radioresistance by preferential activation of the DNA damage response Nature, 444: 756-760
65. 2006 Use of three-dimensional tissue cultures to model extravascular transport and predict in vivo activity of hypoxia-targeted anticancer drugs. J Natl Cancer Inst, 98: 1118-1128
66. 2006 Extracellular pH and P-31 magnetic resonance spectroscopic variables are related to outcome in canine soft tissue sarcomas treated with thermoradiotherapy. Clin Cancer Res, 12: 5733-5740
67. 2006 Three-dimensional imaging of xenograft tumors using optical computed and emission tomography. Med Phys, 33: 3193-3202
68. 2006 Alternative inclusion of fibroblast growth factor receptor 2 exon IIIc in Dunning prostate tumors reveals unexpected epithelial mesenchymal plasticity. Proc Natl Acad Sci U S A, 103: 14116-14121
69. 2006 Preferential extravasation and accumulation of liposomal vincristine in tumor comparing to normal tissue enhances antitumor activity. Cancer Chemother Pharmacol, 58: 245-255
70. 2005 In regard to Arvold et al. (Int J Radiat Oncol Biol Phys 2005;62:207-212). Int J Radiat Oncol Biol Phys, 63: 970-971; author reply 971
71. 2005 A Comparison of Antiangiogenic Therapies for the Prevention of Liver Metastases. J Surg Res
72. 2005 Human recombinant erythropoietin (rEpo) has no effect on tumour growth or angiogenesis. Br J Cancer, 93: 1350-1355
73. 2005 Re-setting the biologic rationale for thermal therapy. Int J Hyperthermia, 21: 779-790
74. 2005 Improved magnetic resonance thermal imaging by combining proton resonance frequency shift (PRFS) and apparent diffusion coefficient (ADC) data. Int J Hyperthermia, 21: 657-667
75. 2005 Thermal medicine, heat shock proteins and cancer. Int J Hyperthermia, 21: 675-677
76. 2005 Camptothecin analogs with enhanced activity against human breast cancer cells. II. Impact of the tumor pH gradient Cancer Chemother Pharmacol, 57: 145-154
77. 2005 Thermal dose is related to duration of local control in canine sarcomas treated with thermoradiotherapy. Clin Cancer Res, 11: 5206-5214
78. 2005 Preferential extravasation and accumulation of liposomal vincristine in tumor comparing to normal tissue enhances antitumor activity. Cancer Chemother Pharmacol 1-11
79. 2005 Method for improved accuracy in endogenous urea recovery marker calibrations for microdialysis in tumors. J Pharmacol Toxicol Methods
80. 2005 Hyperspectral imaging of hemoglobin saturation in tumor microvasculature and tumor hypoxia development. J Biomed Opt, 10: 44004
81. 2005 Spatial heterogeneity and oxygen dependence of glucose consumption in R3230Ac and fibrosarcomas of the Fischer 344 rat. Cancer Res, 65: 5163-5171
82. 2005 Overexpression of extracellular superoxide dismutase reduces acute radiation induced lung toxicity. BMC Cancer, 5: 59
83. 2005 The role of blood-brain barrier permeability in brain tumor imaging and therapeutics. AJR Am J Roentgenol, 185: 763-767,
84. 2005 Pleiotropic effects of HIF-1 blockade on tumor radiosensitivity. Cancer Cell, 8: 99-110
85. 2005 A manganese porphyrin superoxide dismutase mimetic enhances tumor radioresponsiveness. Int J Radiat Oncol Biol Phys, 63: 545-552
86. 2005 Expression of HIF-1alpha, CA IX, VEGF, and MMP-9 in surgically resected non-small cell lung cancer. Lung Cancer, 49: 325-335
87. 2005 In regard to Vasanathan et al. (Int J Radiat Oncol Biol Phys 2005;61:145-153). Int J Radiat Oncol Biol Phys, 63: 644
88. 2005 Cytokine profiling for prediction of symptomatic radiation-induced lung injury. Int J Radiat Oncol Biol Phys
89. 2005 Prospective assessment of quality of life in ovarian cancer patients receiving whole abdomen hyperthermia and liposomal doxorubicin Int J Hyperthermia, 21: 349-357
90. 2005 Observation of incipient tumor angiogenesis that is independent of hypoxia and hypoxia inducible factor-1 activation. Cancer Res, 65: 5498-5505
91. 2005 Phase I/II trial of intravenous Doxil and whole abdomen hyperthermia in patients with refractory ovarian cancer. Int J Hyperthermia, 21: 333-347
92. 2005 Oxygen Regulation of Tumor Perfusion by S-Nitrosohemoglobin Reveals a Pressor Activity of Nitric Oxide. Circ Res, 96: 1119-26
93. 2005 Development of magnetic resonance imaging contrast material for in vivo mapping of tissue transglutaminase activity. Cancer Res, 65: 1369-1375
94. 2005 Randomized trial of hyperthermia and radiation for superficial tumors. J Clin Oncol, 23: 3079-3085
95. 2005 Relation between pO2, 31P magnetic resonance spectroscopy parameters and treatment outcome in patients with high-grade soft tissue sarcomas treated with thermoradiotherapy. Int J Radiat Oncol Biol Phys, 61: 480-491
96. 2005 Predicting radiotherapy-induced cardiac perfusion defects Med Phys, 32: 19-27
97. 2005 Recent progress in defining mechanisms and potential targets for prevention of normal tissue injury after radiation therapy. Int J Radiat Oncol Biol Phys, 62: 255-259
98. 2004 The role of hyperthermia in regional alkylating agent chemotherapy. Clin Cancer Res, 10: 5919-5929
99. 2004 Enhancement of hypoxia-induced tumor cell death in vitro and radiation therapy in vivo by use of small interfering RNA targeted to hypoxia-inducible factor-1alpha. Cancer Res, 64: 8139-8142
100. 2004 Proton and hyperpolarized helium magnetic resonance imaging of radiation-induced lung injury in rats. Int J Radiat Oncol Biol Phys, 58: 1562-1569
101. 2004 In vivo monitoring of tissue pharmacokinetics of liposome/drug using MRI: illustration of targeted delivery. Magn Reson Med, 51: 1153-1162
102. 2004 Green's function methods for analysis of oxygen delivery to tissue by microvascular networks. Ann Biomed Eng, 32: 1519-1529
103. 2004 Synergistic effects of hyperoxic gas breathing and reduced oxygen consumption on tumor oxygenation: a theoretical model. Int J Radiat Oncol Biol Phys, 59: 572-578
104. 2004 Use of in vivo bioluminescence imaging to predict hepatic tumor burden in mice. J Surg Res, 120: 249-255
105. 2004 Effect of calcitonin gene related peptide vs sodium nitroprusside to increase temperature in spontaneous canine tumours during local hyperthermia. Int J Hyperthermia, 20: 477-489
106. 2004 Functional significance of Tie2 signaling in the adult vasculature. Recent Prog Horm Res, 59: 51-71
107. 2004 Raising the bar: how HIF-1 helps determine tumor radiosensitivity. Cell Cycle, 3: 1107-1110
108. 2004 Radiation activates HIF-1 to regulate vascular radiosensitivity in tumors: role of reoxygenation, free radicals, and stress granules Cancer Cell, 5: 429-441
109. 2004 Predicting the effect of temporal variations in PO2 on tumor radiosensitivity. Int J Radiat Oncol Biol Phys, 59: 822-833
110. 2004 Carbonic anhydrase IX in early-stage non-small cell lung cancer Clin Cancer Res, 10: 7925-7933
111. 2004 Thermochemoradiotherapy improves oxygenation in locally advanced breast cancer. Clin Cancer Res, 10: 4287-4293
112. 2004 Nitroxide conjugate of a thermally responsive elastin-like polypeptide for noninvasive thermometry. Med Phys, 31: 2755-2762
113. 2004 Feasibility of optimizing the dose distribution in lung tumors using fluorine-18-fluorodeoxyglucose positron emission tomography and single photon emission computed tomography guided dose prescriptions. Med Phys, 31: 1452-1461
114. 2004 Targeting tumor microvessels using doxorubicin encapsulated in a novel thermosensitive liposome. Mol Cancer Ther, 3: 1311-1317
115. 2004 Tumor-dependent kinetics of partial pressure of oxygen fluctuations during air and oxygen breathing. Cancer Res, 64: 6010-6017
116. 2004 2 gene amplification correlates with higher levels of angiogenesis and lower levels of hypoxia in primary breast tumors. Clin Cancer Res, 10: 4083-4088
117. 2004 Circulating D-dimer levels are better predictors of overall survival and disease progression than carcinoembryonic antigen levels in patients with metastatic colorectal carcinoma. Cancer, 101: 77-82,
118. 2003 Ultrasound guided pO2 measurement of breast cancer reoxygenation after neoadjuvant chemotherapy and hyperthermia treatment. Int J Hyperthermia, 19: 498-506
119. 2003 Glutathione depletion or radiation treatment alters respiration and induces apoptosis in R3230Ac mammary carcinoma. Adv Exp Med Biol, 530: 153-164
120. 2003 Dietary glycine inhibits angiogenesis during wound healing and tumor growth. Cancer Biol Ther, 2: 173-178,
121. 2003 Human recombinant erythropoietin significantly improves tumor oxygenation independent of its effects on hemoglobin. Cancer Res, 63: 6162-6165
122. 2003 Comparison of fluctuations of oxygen tension in FSA, 9L, and R3230AC tumors in rats. Adv Exp Med Biol, 510: 7-12
123. 2003 Those in gene therapy should pay closer attention to lessons from hyperthermia. Int J Radiat Oncol Biol Phys, 57: 597-599; author reply 599-600
124. 2003 Basic principles of thermal dosimetry and thermal thresholds for tissue damage from hyperthermia. Int J Hyperthermia, 19: 267-294
125. 2003 Carcinogenic effects of hyperthermia. Int J Hyperthermia, 19: 236-251
126. 2003 Mechanisms underlying hypoxia development in tumors. Adv Exp Med Biol, 510: 51-56
127. 2003 Effect of longitudinal oxygen gradients on effectiveness of manipulation of tumor oxygenation. Cancer Res, 63: 4705-4712,
128. 2003 Concerted regulation of skeletal muscle contractility by oxygen tension and endogenous nitric oxide. Proc Natl Acad Sci U S A, 100: 15229-15234
129. 2003 The activity of camptothecin analogues is enhanced in histocultures of human tumors and human tumor xenografts by modulation of extracellular pH. Cancer Chemother Pharmacol, 52: 253-261
130. 2003 conclusions and recommendations: adverse temperature levels in the human body. Int J Hyperthermia, 19: 373-384
131. 2003 A pilot Phase II trial of concurrent radiotherapy, chemotherapy, and hyperthermia for locally advanced cervical carcinoma. Cancer, 98: 277-282
132. 2003 Overexpression of extracellular superoxide dismutase protects mice from radiation-induced lung injury. Int J Radiat Oncol Biol Phys, 57: 1056-1066
133. 2003 A mathematical model of tumor oxygen and glucose mass transport and metabolism with complex reaction kinetics. Radiat Res, 159: 336-344
134. 2003 Effects of cell damage and glycosaminoglycan degradation on available extravascular space of different dextrans in a rat fibrosarcoma. Int J Hyperthermia, 19: 154-164
135. 2003 Effect of mild hyperglycemia +/- meta-iodo-benzylguanidine on the radiation response of R3230 Ac tumors. Adv Exp Med Biol, 530: 177-186
136. 2003 A clinical model of dermal wound angiogenesis. Wound Repair Regen, 11: 306-313
137. 2003 Reduction of wound angiogenesis in patients treated with BMS-275291, a broad spectrum matrix metalloproteinase inhibitor. Clin Cancer Res, 9: 586-593
138. 2003 Synergy between tumor immunotherapy and antiangiogenic therapy. Blood, 102: 964-971
139. 2003 The effect of nicotinamide & hyperoxic gases on blood glucose. Adv Exp Med Biol, 510: 375-378
140. 2003 Accuracy of MRI in the detection of residual breast cancer after neoadjuvant chemotherapy. AJR Am J Roentgenol, 181: 1275-1282
141. 2003 A novel rodent mammary window of orthotopic breast cancer for intravital microscopy. Microvasc Res, 65: 109-117
142. 2003 Endoscopic components separation for abdominal compartment syndrome. Am J Surg, 186: 158-163
143. 2003 A. Inhibition of rat corneal angiogenesis by a nuclease-resistant RNA aptamer specific for angiopoietin-2. Proc Natl Acad Sci U S A, 100: 5028-5033
144. 2003 Increased resistance of tumor cells to hyperthermia mediated by integrin-linked kinase. Clin Cancer Res, 9: 1155-1160
145. 2002 Hyperthermia-regulated immunogene therapy Int J Hyperthermia, 18: 586-596
146. 2002 A small molecular weight catalytic metalloporphyrin antioxidant with superoxide dismutase (SOD) mimetic properties protects lungs from radiation-induced injury. Free Radic Biol Med, 33: 857-863
147. 2002 A. B. Intravascular location of breast cancer cells after spontaneous metastasis to the lung. Am J Pathol, 161: 749-753
148. 2002 Toward a national consensus: teaching radiobiology to radiation oncology residents. Int J Radiat Oncol Biol Phys, 54: 861-872
149. 2002 A theoretical model for the effects of reduced hemoglobin-oxygen affinity on tumor oxygenation Int J Radiat Oncol Biol Phys, 53: 172-179
150. 2002 SU5416 delays wound healing through inhibition of TGF-beta 1 activation Cancer Biol Ther, 1: 121-126
151. 2002 Hypoxia in the thymus: role of oxygen tension in thymocyte survival. Am J Physiol Heart Circ Physiol, 282: H1467-1477
152. 2002 Toward a consensus on radiobiology teaching to radiation oncology residents Radiat Res, 157: 599-606
153. 2002 Intravital fluorescence facilitates measurement of multiple physiologic functions and gene expression in tumors of live animals Dis Markers, 18: 293-311
154. 2001 Effective tumor therapy with plasmid-encoded cytokines combined with in vivo electroporation Cancer Res 61:3281-3284
155. 2001 Transcriptional response to hypoxia in human tumors J Natl Cancer Inst 93:1337-1343
156. 2001 A phase II trial testing the thermal dose parameter CEM43 ° T90 as a predictor of response in soft tissue sarcomas treated with pre-operative thermoradiotherapy Int J Hyperthermia 17: 283-290
157. 2001 Radiation-induced hypoxia may perpetuate late normal tissue injury Int J Radiat Oncol Biol Phys 50:851-855
158. 2001 Persistent genetic instability in cancer cells induced by non-DNA- damaging stress exposures Cancer Res. 61:428-432
159. 2001 Mechanismsed associated with tumor vascular shut-down induced by combretastatin A-4 Phosphate: Intravital microscopy and measurement of vascular permeability Cancer Res 61:6413-6422
160. 2001 Drug targeting using thermally responsive polymers and local hyperthermia , J Control Release 74:213-214
161. 2001 Circumventing tamoxifen resistance in breast cancers using antiestrogens that induce unique conformational changes in the estrogen receptor Cancer Res 61:2917-2922
162. 2001 Comparison of tumor and normal tissue oxygen tension measurements using oxylite or microelectrodes in rodents Am J Physiol Heart Circ Physiol 280:2533-2544
163. 2001 Elevated tumor lactate concentrations predict for an increased risk of metastases in head and neck cancer Int J Radiat Oncol Biol Phys 51:349-353
164. 2001 Simultaneous administration of glucose and hyperoxic gas achieves greater improvement in tumor oxygenation than hyperoxic gas alone Int J Radiat Oncol Biol Phys 51:494-506
165. 2001 Targeting a genetically engineered elastin-like polypeptide to solid tumors by local hyperthermia Cancer Res 61:1548-1554
166. 2001 In vivo bold contrast MRI mapping of subcutaneous vascular function and maturation: Validation by intravital microscopy Magn Reson Med 45:887-898
167. 2001 Urea as a recovery marker for quantitative assessment of tumor interstitial solutes with microdialysis Cancer Res, 61:7964-7970
168. 2001 Tissue gradients of energy metabolites mirror oxygen tension gradients in a rat mammary carcinoma model Int J Radiat Oncol Biol Phys 51:494-506
169. 2001 The novel tubulin-binding drug BTO-956 inhibits R3230 Ac mammary carcinoma growth and angiogenesis in Fischer 344 rats Clin Cancer Res 7:2590-2596
170. 2001 A bayesian model for detecting changes in nonlinear profiles JASA 96:1215-1222
171. 2001 Effects of the interaction between carbogen and nicotinamide on R3230 Ac tumor blood flow in Fischer 344 rats Radiation Research 155:724-733
172. 2001 The development and testing of a new temperature-sensitive drug delivery system for the treatment of solid tumors Advanced Drug Delivery Reviews 53:285-305
173. 2001 Variability in blood flow and pO2 in tumors in response to carbogen breathing Photochem Photobiol 74:700–706
174. 2001 Systemic vector leakage and transgene expression by intratumorally injected recombinant adenovirus vectors Clin Cancer Res 7:3625-3628
175. 2001 Characterization of the effect of hyperthermia on nanoparticle extravasation from tumor vasculature Cancer Res 61:3027-3032
176. 2000 Enhancement of radiotherapy by hyperthermia-regulated gene therapy Int J Radiat Oncol Biol Phys 48:1513-1518
177. 2000 Role of incipient angiogenesis in cancer metastasis Cancer and Metastasis reviews 19:7-11
178. 2000 A new temperature-sensitive liposome for use with mild hyperthermia: characterization and testing in a human tumor xenograft model Cancer Res 60:1197-1201
179. 2000 Efficacy of liposomes and hyperthermia in a human tumor xenograft model: Importance of triggered drug release Cancer Res 60:6950-6957
180. 2000 A pilot study of preoperative continuous infusion 5-fluorouracil, external microwave hyperthermia, and external beam radiotherapy for treatment of locally advanced, unresectable, or recurrent rectal cancer Int J Radiat Oncol Biol Phys 47:719-724
181. 2000 Local 42° C hyperthermia improves vascular conductance of the R3230Ac rat mammary adenocarcinoma during sodium nitroprusside infusion , Radiat Res 154:196-201
182. 2000 Interstitial hydraulic conductivity in a fibrosarcoma Am J Physiol Heart Circ Physiol 279:2726-2734
183. 2000 Review of methods used to study oxygen transport at the microcirculatory level Int J Cancer 90:237-255
184. 2000 Tamoxifen inhibits angiogenesis in estrogen receptor-negative animal models Clin Cancer Res 6:4359-4364
185. 2000 Acute pancreatitis assocciated with administration of a nitric oxided synthase inhibitor in tumor-bearing dogs In Vivo 14:709-714
186. 2000 Camptothecin analogues with enhanced antitumor activity at acidic pH Cancer Chemother Pharmacol 46:263-271
187. 2000 Hyperthermia enables tumor-specific nanoparticle delivery: Effect of particle size Cancer Res 60:4440-4445
188. 2000 Heat-induced gene expression as a novel targeted cancer gene therapy strategy Cancer Res 60:3435-3439
189. 2000 Using units of CEM 43oC T90, local hyperthermia thermal dose can be delivered as prescribed Int J Hyperthermia 16:415-428
190. 2000 The relationship between intracellular and extracellular pH in spontaneous canine tumors Clin Cancer Res 6:2501-2505
191. 2000 Early wound healing exhibits cytokine surge without evidence of hypoxia , Ann Surg 231:137-147
192. 2000 Plasma D-dimer levels in operable breast cancer patients correlate with clinical stage and axillary lymph node status J Clin Oncol 18:600-608
193. 2000 Use of Hyperthermia to Augment Liposomal Drug Delivery to Tumours, In: Radiation Research Volume 2 Allen Press, Lawrence, KA, pp 853 - 856
194. 2000 Modulation of tumor blood flow by nitric oxide, In: Radiation Research Volume 2 Allen Press, Lawrence, KA, pp 610 - 613
195. 2000 Initial stages of tumor cell-induced angiogenesis: Evaluation via skin window chambers in rodent models J Nat Cancer Inst 92:143-147
196. 2000 Combination treatment of murine tumors by adenovirus-mediated local B7/IL1 immunotherapy and radiotherapy Mol Ther 2:195-203
197. 2000 Temperature dependent changes in physiologic parameters of spontaneous canine soft tissue sarcomas after combined radiotherapy and hyperthermia treatment Int J Radiat Oncol Biol Phys 46:179-185
198. 1999 Glutathione depletion or radiation treatment alters respiration and induces apoptosis in R3230Ac mammary carcinoma, Proceedings of the 1999 ISOTT conference Dartmouth
199. 1999 Ascaris haemoglobin is a nitric oxide-activated 'deoxygenase Nature 401:497-502
200. 1999 Analysis of oxygen transport to tumors: Causes of heterogenous tissue oxygenation, Bioengineering Conference, Big Sky Montana June 16-20, BED Vol. 42, pp 487-488
201. 1999 GFP based non-invasive, in vivo monitoring of gene expression Nat Biotechnol 17:1033-1035
202. 1999 Three-dimensional microvascular networks fractal structure: potential for tissue characterization ASME Proceedings
203. 1999 Oxygenation of head and neck cancer: Changes during radiotherapy and impact on treatment outcome Radiat Oncol 53:113-117
204. 1999 Tissue transglutaminase is expressed, active, and directly involved in rat dermal wound healing and angiogenesis Faseb J 13:1787-1795
205. 1999 Fourier analysis of fluctuations of oxygen tension and blood flow in R3230Ac tumors and muscle in rats Am J Physiol 277:551-568
206. 1999 The treatment of high grade soft tissue sarcomas with preoperative thermoradiotherapy Int J Radiat Oncol Biol Phys 45:941-949
207. 1999 Hyperthermia and liposomes: a review Int J Hyperthermia 15:345-370
208. 1999 Use of whole body hyperthermia as a method to heat inaccessible tumors uniformly: A phase III trial in canine brain masses Int J Hyperthermia 15:383-398
209. 1999 Available volume fraction of macromolecules in a fibrosarcoma: Implication for drug delivery Cancer Res 59:4136-4141
210. 1999 The effects of hyperoxic and hypercarbic gases on tumour blood flow Br J Cancer 80:117-126
211. 1999 Quantification of longitudinal tissue p02 gradients in window chamber tumors: Impact on tumor hypoxia Br J Cancer 79:1717-1722
212. 1999 Tissue transglutaminase is expressed as a host response to tumor invasion and inhibits tumor growth Lab Invest 79:1679-1686
213. 1999 Tumour cell kinetics as predictors of response in canine lymphoma treated with chemotherapy alone or combined with whole body hyperthermia Int J Hyperthermia 15: 475-486
214. 1999 Effect of mild hyperglycemia +/- meta-iodo-benzylguanidine on the radiation response of R3230 AC tumors. Proceedings of the 1999 ISOTT conference Dartmouth
215. 1998 Variability in blood flow and pO2 in tumors in response to carbogen breathing Int J Radiat Oncol Biol Phys 42:855-859
216. 1998 Temporal changes in pO2 of R3230Ac tumors in Fischer-344 rats Int J Radiat Oncol Biol Phys 42:723-726
217. 1998 MIBG inhibits respiration: potential for radio-and hyperthermia sensitization Int J Radiat Oncol Biol Phys 42:871-876
218. 1998 Antiangiogenic gene therapy targetting the endothelium-specific receptor tyrosine kinase Tie2 PNAS 95:8829-8834
219. 1998 Theoretical simulation of oxygen transport to tumors by three-dimensional networks of microvessels Adv Exp Med Biol 454: 629-634
220. 1998 Oxygen distributions within R3230Ac tumors growing in dorsal flap window chambers in rats Adv Exp Med Biol 454: 603-609
221. 1998 Further justification for development of non-invasive thermometry [editorial; comment] Int JHyperthermia 14:255
222. 1998 Should interstitial thermometry be used for deep hyperthermia? Int J Radiat Oncol Biol Phys 40:1015-1017
223. 1998 Concepts of oxygen transport at the microcirculatory level Semin Radiat Oncol 8:143-150
224. 1998 The multifaceted roles of NO in cancer Carcinogenesis 19:711-712
225. 1998 Serial in vivo observations of cerebral vasculature after treatment with a large single fraction of radiation Radiat Res 149:350-359
226. 1998 Inhibition of tumor growth by targeting tumor endothelium using a soluble vascular endothelial growth factor receptor Cell Growth Differ 9:49-58
227. 1998 Artificial neural network model of survival in patients treated with irradiation with and without concurrent chemotherapy for advanced carcinoma of the head and neck Int J Radiat Oncol Biol Phys 41:339-345
228. 1997 Tie2 expression and phosphorylation in angiogenic and quiescent adult tissues Circ Res 81:567-574
229. 1997 Inhibition of tumor angiogenesis using a soluble receptor establishes a role for Tie2 in pathologic vascular growth J Clin Invest 100:2072-2078
230. 1997 Interlaboratory variation in oxygen tension measurement by Eppendorf “histograph” and comparison with hypoxic marker J Surg Oncol 66:30-38
231. 1997 Hyperbaric oxygen improves tumor radiation response significantly more than carbogen/nicotinamide Radiat Res 147:715-720
232. 1997 Tie2 expression and phosphyorylation of angiogenic and quiescent adult tissues Circ Res 81:567-574
233. 1997 Tumor hypoxia adversely affects to prognosis of carcinoma of the head and neck Int J Radiat Oncol Biol Phys 38:285-289
234. 1997 A local hyperthermia treatment which enhances antibody uptake in a glioma xenograft model does not affect tumour interstitial fluid pressure , Int J Hyperthermia 13:307-316
235. 1997 Stroma-free human hemoglobin A decreases R3230Ac rat mammary adenocarcinoma blood flow and oxygen partial pressure Radiat Res 147:185-194
236. 1997 Quantification of erythrocyte flow in the choroid Am J Physiol 272:1444-1453
237. 1997 Combine external beam irradiation and external regional hyperthermia for locally advanced adenocarcinoma of the prostate Int J Radiat Oncol Biol Phys 37:1059-1065
238. 1997 Local hyperthermia improves uptake of a chimeric monoclonal antibody in a subcutaneous xenograft model Clin Cancer Res 3:63-70
239. 1997 Effects of diethylamine/nitric oxide on blood perfusion in the R3230Ac mammary carcinoma Br J Cancer 76:429-437
240. 1996 Phase I evaluation of mitoxantrone alone and combined with whole body hyperthermia in dogs with lymphoma Int J Hyperthermia 12: 309-320
241. 1996 Tissue transgluminase expression in human breast cancer Lab Invest 75:637-645
242. 1996 Monitoring of neoadjuvant therapy response of soft tissue and musculoskeletal sarcomas using F18-FDG PET: Initial evaluation , J Nucl Med 37:1438-1444
243. 1996 Fluctuations in red cell flux in tumor microvessels lead to transient hypoxia and reoxygenation in tumor parenchyma Cancer Res 56:5522-5528
244. 1996 Radiation therapy and hyperthermia improve the oxygenation of human soft tissue sarcomas Cancer Res 56:5347-5350
245. 1996 Radiation plus local hyperthermia versus radiation plus the combination of local and whole body hyperthermia in canine sarcomas Int J Radiat Oncol Biol Phys 34:1087-1096
246. 1996 Estimation of cell survival in tumors heated to nonuniform temperature distributions Int J Hyperthermia 12:223-239
247. 1996 Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma Cancer Res 56:941-943
248. 1996 Arteriolar oxygenation in tumor and subcutaneous arterioles: Effects of inspired air oxygen content Br J Cancer 74:247-251
249. 1996 Microvascular studies on the origins of perfusion-limited hypoxia Br J Cancer 74:241-246
250. 1996 Tumor oxygenation: A matter of supply and demand AntiCancer Res 16:741-749
251. 1996 Calcium-dependent nitric oxide release in EA.hy926 endothelial but not R3230Ac rat mammary adenocarcinoma cells Am J Physiol 271:332-337
252. 1996 Thrall DE, Measuring tumor hypoxia Semin Radiat Oncol 6:37-45
253. 1996 The effects of clinically relevant hyperthermic temperatures on the kinetic binding parameters of a monoclonal antibody Nucl Med Biol 23:551-557
254. 1996 Papahadjopoulos D, Thermosensitive liposomes: Extravasation and release of contents in tumor microvascular networks Int J Radiat Oncol Biol Phys 36:1177-1187
255. 1996 Two approaches for enhancing radioimmunotherapy: alpha emitters and hyperthermia Recent Results Cancer Res 141: 101-122
256. 1995 Craniofacial implants in irradiated bone: clinical and laboratory experiences. Proceedings of the First International Congress on Maxillofacial Prosthetics New York: Memorial Sloan-Kettering Cancer Center, 1995), pp. 297-304
257. 1995 Inhibition of radiation-induced up-regulation of leukocyte adhesion to endothelial cells with the platelet activating factor inhibitor, BN52021 Int J Radiat Oncol Biol Phys 33:627-633
258. 1995 Patterns and variability of tumor oxygenation in human soft tissue sarcomas, cervical carcinomas, and lymph node metastases Int J Radiat Oncol Biol Phys 32:1121-1125
259. 1995 A pial window model for the intracranial study of human glioma microvascular function, Neurosurgery 36:976-985
260. 1995 Progress toward a thermal dosimetry system [editorial comment Int J Radiat Oncol Biol Phys 33:963-964
261. 1995 Hyperthermic modulation of radiolabeled antibody uptake in a human glioma xenograft and normal tissues Int J Hyperthermia 11:59-72
262. 1995 The mechanisms by which hyperbaric oxygen and carbogen improve tumor oxygenation Br J Cancer 72:1120-1124
263. 1995 Flunarizine enhancement of melphalan activity against drug sensitive/resistant rhabdomyosarcoma, Br J Cancer 71:1181-1187
264. 1995 Nitric oxide synthase inhibition irreversibly decreases perfusion in the R3230Ac rat mammary adenocarcinoma Br J Cancer 71:1169-1174
265. 1995 Analysis of the effects of oxygen supply and demand on hypoxic fraction in tumors Acta Oncologica 34:313-316
266. 1995 Tumor physiology and cell kinetics Semin Vet Med Surg Small Anim 10: 148-157
267. 1994 The effect of the perflubron emulsion Oxygentâ„¢ on the calibration characteristics of polarographic oxygen electrodes Radiat Oncol 33:262-265
268. 1994 MR imaging and spectroscopy for prognostic evaluation in soft-tissue sarcomas Radiology 190:269-275
269. 1994 Reduction in tumor blood flow in skin flap tumor after hydralazine is not due to a vascular steal phenomenon Radiat Oncol Invest 1:270-278
270. 1994 Differences in leucocyte-endothelium interactions between normal and adenocarcinoma bearing tissues in response to radiation Br J Cancer 69:883-889
271. 1994 Pretreatment oxygenation profiles of human soft tissue sarcomas Int J Radiat Oncol Biol Phys 30:635-642
272. 1994 Therapy monitoring in human and canine soft tissue sarcomas using magnetic resonance imaging and spectroscopy Int J Radiat Oncol Biol Phys 28:415-423
273. 1994 Effect of whole-body hyperthermia on carboplatin disposition and toxicity in dogs Int J Hyperthermia 10:807-816
274. 1994 Future directions in hyperthermia biology Int J Hyperthermia 10:339 345
275. 1994 Hyperthermic sensitization by the radial initiator 2,2’-azobis (2-amidinopropane) dihydrochloride (AAPH): I. In vitro studies Int J Hyperthermia 10:271-281
276. 1994 Inverse techniques in hyperthermia: A sensitivity study IEEE Trans Biomed Eng 41:373-382,
277. 1994 Determination of local oxygen consumption rates in tumors Cancer Res 54:3333-3336
278. 1993 Intersociety Council on Radiation Oncology essay on the introduction of new medical treatments into practice J Nat Cancer Inst 85:951-957
279. 1993 The effect of flunarizine on erythrocyte suspension viscosity under conditions of extreme hypoxia, low pH, and lactate treatment Br J Cancer 67:734-741
280. 1993 Development of a model of melphalan-induced gastrointestinal toxicity in mice. Cancer Chemother Pharmacol 31:376-380
281. 1993 Increased microvascular permeability contributes to preferential accumulation of Stealthâ„¢ liposomes in tumor tissue Cancer Res 53:3765-3770
282. 1993 Manipulation of intra- and extracellular pH in spontaneous canine tumours by use of hyperglycaemia Int J Hyperthermia 9:745-754
283. 1993 The lack of impact of treatment time on the outcome of definitive radiotherapy for carcinoma of the prostate. Int J Radiat Oncol Biol Phys 3:707-711
284. 1993 A comparison of tumor and normal tissue microvascular hematocrits and red cell fluxes in a rat window chamber model Int J Radiat Oncol Biol Phys 25:269-27
285. 1993 Sensitivity of hyperthermia trial outcomes to temperature and time: Implications for thermal goals of treatment Int J Radiat Oncol Biol Phys 25:289-297
286. 1993 Analysis of oxygen transport to tumor tissue by microvascular networks Int J Radiat Oncol Biol Phys 25:481-489
287. 1993 Factors influencing hyperthermic enhancement of drug cytotoxicity. Editorial Int J Radiat Oncol Biol Phys 25:569-570
288. 1993 Cumulative minutes with T90 greater than TEMP index is predictive of response of superficial malignancies to hyperthermia and radiation Int J Radiat Oncol Biol Phys 25:841-847
289. 1993 Therapeutic effect of infused fluosol-DA/carbogen with ephendrine, flunarizine or nitroprusside Therapeutic effect of infused fluosol-DA/carbogen with ephendrine, flunarizine or nitroprusside
290. 1993 Intraperitoneal cisplatin and regional hyperthermia for ovarian carcinoma Int J Radiat Oncol Biol Phys 27:1245-1251
291. 1993 Measurement of material extravasation in microvascular networks using fluorescence video-microscopy Microvasc Res 46:231-253
292. 1993 Pharmacokinetic and phase I evaluation of carboplatin in dogs J Vet Intern Med 7: 235-240
293. 1992 Feasibility of estimating the temperature distribution in a tumor heated by a waveguide applicator Int J Radiat Oncol Biol Phys 23:1009-1019
294. 1992 Diminished leukocyte-endothelium interaction in tumor microvessels Cancer Res 52:4265-4268
295. 1992 Serious toxicity associated with annular microwave array induction of whole-body hyperthermia in normal dogs Int J Hyperthermia 8:23-32
296. 1992 Enhancement of melphalan-induced gastrointestinal toxicity in mice treated with regional hyperthermia and BSO-mediated glutathione depletion Int J Hyperthermia 8:111-120
297. 1992 Phase III evaluation of doxorubicin and whole body hyperthermia in dogs with lymphoma Int J Hyperthermia 8:187-197
298. 1992 Effects of glutathione or polyamine depletion on in vivo thermosensitization Int J Hyperthermia 8:199-208
299. 1992 Response of canine soft tissue sarcomas to radiation or radiation plus hyperthermia: A randomized phase II study Int J Hyperthermia 8:309-320
300. 1992 Quantitative estimation of the thermal dose-modifying factor for cis-diamminedichloroplatinum (CDDP) in tumor-bearing dogs Int J Hyperthermia 8:761-769,
301. 1992 Relationships among tumor temperature, treatment time and histopathological outcome using preoperative hyperthermia with radiation in soft tissue sarcomas Int J Radiat Oncol Biol Phys 22:989-998
302. 1992 Use of nitroprusside to increase tissue temperature during local hyperthermia in normal and tumor-bearing dogs Int J Radiat Oncol Biol Phys 23:377-385
303. 1992 Effects of bradykinin on the hemodynamics of tumor and granulating normal tissue microvasculature Radiat Res 130:345-354
304. 1992 Perivascular oxygen tensions in a transplantable mammary tumor growing in a dorsal flap window chamber Radiat Res 130:171-182
305. 1992 Friedman HS, Hyperthermia-induced enhancement of melphalan activity against a melphalan resistant human rhabdomyosarcoma xenograft Radiat Res 129:218-223
306. 1992 Combining hyperthermia and radiation: How beneficial? Oncology 5:110-112
307. 1992 Phase I evaluation of doxorubicin and whole body hyperthermia in dogs with lymphoma, J Vet Int Med 6:245-249
308. 1992 Polymer-grafted liposomes: Physical basis for the 'Stealth' Property J Liposome Res 2:411-430,
309. 1992 Effects of the calcium channel blocker flunarizine on the hemodynamics and oxygenation of tumor microvasculature Radiat Res 132:61-68
310. 1991 Therapeutic analysis of melphalan-resistant human rhabdomyosarcoma xenograft TE-671MR Cancer Res 51:3906-3909
311. 1991 Accelerated repopulation: Friend or foe? Exploiting changes in tumor growth characteristics to improve the 'efficiency' of radiotherapy Int J Radiat Oncol Biol Phys 21:1377-1383
312. 1991 RTOG quality assurance guidelines for interstitial hyperthermia Int J Radiat Oncol Biol Phys 20:1117-1124,
313. 1991 RTOG quality assurance guidelines for clinical trials using hyperthermia for deep seated malignancy Int J Radiat Oncol Biol Phys 20:1109-1115
314. 1991 RTOG quality assurance guidelines for clinical trials using hyperthermia administered by ultrasound Int J Radiat Oncol Biol Phys 20:1099-1107
315. 1991 Phase I study of melphalan alone and melphalan plus whole body hyperthermia in dogs with malignant melanoma Int J Hyperthermia 7:559-566
316. 1990 Nonuniform alteration of cis-diamminedichloroplatinum (II) tissue distribution in dogs with whole body hyperthermia Cancer Res 50:2075-2080
317. 1990 Enhanced delivery of a monoclonal antibody F(ab')2 fragment to subcutaneous human glioma xenografts using local hyperthermia Cancer Res 50:1803-1809
318. 1990 Blood perfusion measurements in human tumours: Evaluation of laser Doppler methods Int J Hyperthermia 6:287-304
319. 1990 A comparison of temperatures in canine solid tumours during local and whole-body hyperthermia administered alone and simultaneously Int J Hyperthermia 6:305-317
320. 1990 Clinical experience with multi-element ultrasonic hyperthermia system: Analysis of treatment temperatures Int J Hyperthermia 6:909-922
321. 1990 Soft-tissue sarcomas: MR imaging and MR spectroscopy for prognosis and therapy monitoring, Work in progress Radiology 174:847-853
322. 1990 The use of hydralazine to manipulate tumor temperatures during hyperthermia Int J Hyperthermia 6:971-983
323. 1990 Heterogeneity in tumor microvascular response to radiation Int J Radiat Oncol Biol Phys 18:559-568
324. 1990 RTOG quality assurance guidelines for clinical trials using hyperthermia Int J Radiat Oncol Biol Phys 18:1249-1259
325. 1990 Soft tissue sarcomas: Detection of metabolic heterogeneity with P-31 MR spectroscopy Radiology 176:837-843
326. 1989 Characterization of tumour temperature distributions in hyperthermia based on assumed mathematical forms Int J Hyperthermia 5:757-777
327. 1989 A review of treatment planning and dose calculation in veterinary radiation oncology Vet Radiol 30:194-221
328. 1989 Radiotherapy of soft tissue sarcomas in dogs J Am Vet Med Assoc 194:60-63,
329. 1989 Morphologic and hemodynamic comparison of tumor and healing normal tissue microvasculature Int J Radiat Oncol Biol Phys 17:91-99
330. 1989 Animal modeling and thermal dose Radiol Clin North Am 27:509-518
331. 1989 Hyperthermia quality assurance guidelines Int J Radiat Oncol Biol Phys 16:571-587
332. 1989 Tumor temperature distributions predict hyperthermia effect Int J Radiat Oncol Biol Phys 16:559-570
333. 1989 Preoperative hyperthermia and radiation for soft tissue sarcomas: Advantage of two vs. one hyperthermia treatments per week Int J Radiat Oncol Biol Phys 16:107-115
334. 1989 Whole body hyperthermia in dogs using a radiant heating device: Effect of surface cooling on temperature uniformity Int J Hyperthermia 5:137-143
335. 1989 Stability of temperatures during hyperthermia treatments Int J Hyperthermia 5:59-67
336. 1988 Unexpected toxicity associated with use of body surface area for dosing melphalan in the dog Cancer Res 48:288-290
337. 1988 Biological and clinical aspects of hyperthermia in cancer therapy J Clin Oncol 11:368-380
338. 1987 Temporal effects of 5.0 Gy radiation in healing subcutaneous microvasculature of a dorsal flap window chamber Radiat Res 112:581-591
339. 1987 Whole body hyperthermia: Rationale and potential use for cancer treatment Am J Vet Int Med 1:110-120
340. 1987 Whole body hyperthermia and heat sensitizing drugs: A pilot study in canine lymphoproliferative disease Int J Hyperthermia 3:187-198
341. 1987 Clinical application of thermal isoeffect dose Int J Hyperthermia 3:307-318
342. 1987 Automated temperature scanning for hyperthermia treatment monitoring Int J Radiat Oncol Biol Phys 13:1377-1382
343. 1987 Response of canine oral carcinomas to heat and radiation Int J Radiat Oncol Biol Phys 13:1861-1867
344. 1987 Pharmacokinetics and toxicity of intraperitoneal cisplatin combined with regional hyperthermia J Clin Oncol 5:1613-1620
345. 1987 Cardiovascular and metabolic response of tumour-bearing dogs to whole body hyperthermia Int J Hyperthermia 3:513-525
346. 1986 Estimation of therapeutic gain in clinical trials involving hyperthermia and radiotherapy Int J Hyperthermia 2:165-178
347. 1986 Temperature measurements in normal and tumor tissue of dogs undergoing whole body hyperthermia Cancer Res 46:6229-6235
348. 1986 Tyczkowska K, Thrall DE, Effect of hyperthermia on cisplatin pharmocokinetics in normal dogs Int J Hyperthermia 2:351-358
349. 1986 Withrow SJ, Influence of WR 2721 on radiation response of canine soft tissue sarcomas Int J Radiat Oncol Biol Phys 12:1957-1963
350. 1986 Determination of continuous atracurium infusion rate in dogs undergoing whole body hyperthermia Cancer Res 46:5599-5601
351. 1986 Effects of heating rate on normal and tumor microcirculatory function. In: KR Diller and RB Roemer (eds.), Heat and Mass Transfer in the Microcirculation of Thermally Significant Vessels ASME
352. 1985 Use of radiation and/or hyperthermia for treatment of mast cell tumors and lymphosarcoma in dogs Vet Clin North Am Small Anim Pract 15: 835-43
353. 1985 Local control and distant metastases in primary canine malignant melanomas treated with hyperthermia and/or radiotherapy Int J Hyperthermia 1:219-234
354. 1984 Analysis of prognostic variables which influence early and long-term response of pet animal tumors to radiation alone and radiation plus heat Front Radiat Ther Oncol 18: 47-55
355. 1984 Regional hyperthermia by magnetic induction in a beagle dog model: Analysis of thermal dosimetry Radiat Res 98:445-455
356. 1984 Importance of minimum tumor temperature in determining early and long-term responses of spontaneous canine and feline tumors to heat and radiation Cancer Res 44:43-50
357. 1984 The utility of thermal dose as a predictor of tumor and normal tissue responses to combined radiation and hyperthermia Cancer Res 44:4772-4780
358. 1984 Observations on the use of ferromagnetic implants for inducing hyperthermia Trans Biomed Eng 31:76-90
359. 1984 The effect of rate of heating and cooling prior to heating on tumor and normal tissue microcirculatory blood flow Biorheology 21:539-558
360. 1983 Correlation between initial and long term responses of spontaneous pet animal tumors to heat and radiation or radiation alone Cancer Res 43:5735-5741
361. 1982 Liver temperatures in rats subjected to whole body hyperthermia, evidence for congestion and lymphocyte damage J Natl Cancer Inst Monogr
362. 1982 Roth H, In vivo temperature dependence of the speed of sound in mammalian tissue and its possible use in hyperthermia J Natl Cancer Inst Monogr
363. 1982 Response of spontaneous animal tumors to heat and/or radiation: Preliminary results of a Phase III trial J Natl Cancer Inst Monogr
364. 1982 A uniform thermal field in a hyperthermia chamber for microvascular studies Int J Heat Mass Transfer
365. 1980 Will hyperthermia conquer the elusive hypoxic cell: Implications of heat effects on tumor and normal tissue microcirculation Radiology
366. 1978 Electrophoretic evaluation of sera from canine cancer patients Am J Vet Res
367. 1951 Preliminary results of a phase III trial of spontaneous animal tumors to heat and/or radiation: Early normal tissue response and tumor volume influence on initial response Int J Radiat Oncol Biol Phys


4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.